Literature DB >> 33971870

A rare case of ectopic ACTH syndrome with rhabdomyolysis.

Wei Qiang1, Sucai Song1,2, Tianjun Chen3, Zhe Wang4, Jun Feng5, Jiaojiao Zhang6, Hui Guo7.   

Abstract

BACKGROUND: Manifestations of hypokalaemia in ectopic adrenocorticotropic hormonesyndrome(EAS) vary from mild muscle weakness to life-threatening arrhythmia. Herein, we present a rare case of EAS with concomitant rhabdomyolysis(RM) as a result of intractable hypokalaemia. CASE
PRESENTATION: A 64-year-old man was admitted for limb weakness and facial hyperpigmentation for 2 weeks. Lab tests revealed intractable hypokalaemia (lowest at 1.8 mmol/L) and metabolic alkalosis. The diagnosis of RM was based on a creatine kinase(CK)level of 5 times the upper limit. The elevated CK and myohemoglobin (Mb) levels returned to within the normal range after the alleviation of hypokalaemia. The patient was diagnosed with ACTH-dependent Cushing's syndrome (CS) based on unsuppressed serum cortisol after a low-dose dexamethasone suppression test(LDDST) and remarkably elevated ACTH levels. The diagnosis of EAS was made based on the results of a high-dose dexamethasone suppression test(HDDST) and bilateral inferior petrosal sinus sampling(BIPSS). Multiple lymph nodes in the left supraclavicular fossa, right root of neck, mediastinum and bilateral hili of the lung were found with abnormal uptake of 68Ga-DOTA-NOC. Mediastinoscopic lymph node biopsy was performed. The pathological diagnosis was small-cell and large-cell neuroendocrine carcinoma with positive ACTH staining. The patient was prescribed mifepristone and received one cycle of chemotherapy. The patient could not tolerate subsequent chemotherapy and died of dyscrasia.
CONCLUSIONS: RM is a rare complication of EAS with insidious onset and atypical clinical manifestations. Serum potassium levels should be vigilantly monitored to avoid RM in EAS.

Entities:  

Keywords:  Cushing’s syndrome; Ectopic ACTH syndrome; Hypokalaemia; Rhabdomyolysis

Year:  2021        PMID: 33971870     DOI: 10.1186/s12902-021-00755-0

Source DB:  PubMed          Journal:  BMC Endocr Disord        ISSN: 1472-6823            Impact factor:   2.763


  2 in total

1.  Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage.

Authors:  J H Rees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

Review 2.  Rhabdomyolysis: advances in diagnosis and treatment.

Authors:  Ram Parekh; David A Care; Christopher R Tainter
Journal:  Emerg Med Pract       Date:  2012-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.